CDTI invests in Integra Therapeutics, together with Invivo, Columbus, and AdBio Partners

by CDTI Innovación

Innvierte SICC of CDTI Innovación invests in Integra Therapeutics, together with three co-investors, to develop a gene-editing platform for the treatment of oncological, autoimmune, and genetic disea...

Read more

Integra Therapeutics closes a €10.7 million funding round, with participation from Columbus, EIC Fund, CDTI, Invivo, Takeda, and AdBio

by CDTI Innovación

The funds will be used to incorporate new advances into the FiCAT gene writing platform, validate various next generation CAR-T therapies in the preclinical phase and expand the FiCAT cell engineering...

Read more

Integra Therapeutics, backed by Columbus and Invivo, to receive up to €10.5 million from European Commission for its FiCAT advanced therapies platform

by Columbus Venture Partners

Integra Therapeutics, a global leader in creating cutting-edge gene writing tools to make advanced therapies safer and more effective, will receive a grant of €2.5 million and equity investment of u...

Read more

Financiación de 3,8M€ por parte del CDTI para diseñar proteínas mediante inteligencia artificial

by CDTI Innovación

Investigadores de las empresas VIVEbiotech, Integra Therapeutics y OneChain Immunotherapeutics, el Departamento de Medicina y Ciencias de la Vida de la Universidad Pompeu Fabra (UPF), el Instituto de ...

Read more

Integra Therapeutics closes a new investment of €1.5M with the addition of Columbus Venture Partners to seed round

by Columbus Venture Partners

Integra Therapeutics, a biotechnology company that creates next generation gene writing tools, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. T...

Read more

Integra Tx secures €4.5-million in funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures

by Invivo Capital

Integra Therapeutics (Integra Tx), a biotechnology company that is creating next-generation gene editing tools to boost the efficiency and safety of advanced therapies, has completed its first round o...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream